Category: Dual Diagnosis

Explore the complexities of dual diagnosis, where mental health disorders and substance abuse intersect. Learn about specialized treatment plans and holistic approaches for effective management.

Our Blogs

man consulting with a therapist
Dual Diagnosis

Complex Post-Traumatic Stress Disorder (CPTSD)

It’s becoming the norm to discuss post-traumatic stress disorder PTSD. For several years, it was mostly diagnosed only to soldiers coming home from war, but

depressed man mixing Zoloft and Alcohol
Alcohol

Risks of Mixing Zoloft and Alcohol

Mixing antidepressants and alcohol is not recommended, as alcohol can worsen depression symptoms. Learn more about the risks of mixing Zoloft and Alcohol.

person holding a drink and pills
Alcohol

Klonopin and Alcohol

Mixing alcohol with prescription medications can cause several potential side effects, some of which can be life-threatening. This is especially true when mixing Klonopin and

ptsd and addiction
Dual Diagnosis

PTSD and Addiction

Individuals with post-traumatic stress disorder (PTSD) are more susceptible to developing a drug addiction. Studies have shown a 50% prevalence of substance use disorder (SUD)

benefits of dual diagnosis treatment
Dual Diagnosis

Benefits of Dual Diagnosis Treatment

Many patients struggling with a substance use disorder (SUD) often have another underlying mental health disorder. Dealing with a drug or alcohol problem and a

cocaine-and-depression
Cocaine

Cocaine Addiction and Depression

Cocaine is a highly addictive drug that elevates your energy, attention, and alertness. People suffering from depression and other mental health illnesses use cocaine to

marijuana-and-antidepressants
Depression

Risks of Mixing Marijuana and Antidepressants

Given the amount of attention around medicinal marijuana’s potential benefits, it’s tempting to assume that this substance is safer than others.  Marijuana, however, carries several

dangers-of-self-medicating
Dual Diagnosis

Dangers of Self Medicating

According to the National Center for Biotechnology Information, an estimated 9.2% and 11.1% of the population was affected by mood and anxiety disorders.  They also